Thank you to all the people who could join us at St Anne’s College in Oxford for the 5th ACST-2 Collaborators’ Meeting in September. The Meeting was a great success with many interesting presentations and a wonderful Gala dinner at the splendid Divinity school. Scroll down to view the pictures!

For those who missed it, the talks of the meeting can be viewed below and the full programme here.

Please save the date of our next ACST-2 Collaborators' Meeting which will take place alongside the ESVS Annual Meeting in Valencia on 24-28 September 2018.

Monday 4th September 2017

Session 1

• ACST-2 Update - Alison Halliday & Richard Bulbulia
• Aiming for complete data - Alison Clarke & Wojciech Brudlo
• MRI Sub-study - Leo Bonati & Mandy Műller
• Volume of infarcts and procedural risk - Rodolfo Pini

Session 2

• Results from Swedish Carotid Registry Studies: What should we believe? - Peter Gillgren & Anders Gottsäter
• Worldwide burden of stroke in the Global Burden of Disease Study - Derrick Bennett
• 30,000 patients randomised to HDL-raising therapy vs placebo: REVEAL revealed - Louise Bowman
• Pre-dinner talk - Richard Peto

Tuesday 5th September 2017

Session 3

• Dementia and vascular disease - Sarah Pendlebury
• Long-term follow-up of ACST-1 - Mary Sneade & Rebecca Llewellyn-Bennett
• Italian Innovation: Membrane mesh covered stents have a bright future - the iron-guard study - Laura Capoccia
• Italian innovation: Proximal protection device: Mo.Ma. - Antonio Lauricella
• Italian Innovation: Membrane covered stents, MoMa and Filters may all help make CAS safer! - What determines my choice of stent -

• Larissa registry of CAS and CEA - Konstantinos Spanos & Athanasios Giannoukas

Session 4

• ECST-2 and ACTRIS Update - Leo Bonati
• CREST-2 Update - Kevin M Barrett
• Efforts put into ACST-2 recruitment – why patients were NOT randomised for the trial - Barbara Rantner
• Recruitment! - Alison Halliday & Richard Bulbulia